Kronos Bio, Inc. Quarterly Liabilities, Current in USD from Q4 2019 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary: Kronos Bio, Inc. quarterly Liabilities, Current history and growth rate from Q4 2019 to Q3 2024.
Kronos Bio, Inc. Liabilities, Current for the quarter ending September 30, 2024 was $15.4M, a 40.1% decline year-over-year.

Liabilities, Current, Quarterly (USD)

Liabilities, Current, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	$15.4M	-$10.3M	-40.1%	Sep 30, 2024	10-Q	2024-11-13
Q2 2024	$16.6M	-$5.42M	-24.6%	Jun 30, 2024	10-Q	2024-08-08
Q1 2024	$19M	-$6.23M	-24.7%	Mar 31, 2024	10-Q	2024-05-09
Q4 2023	$24.7M	+$3.21M	+14.9%	Dec 31, 2023	10-Q	2024-11-13
Q3 2023	$25.7M	+$5.57M	+27.7%	Sep 30, 2023	10-Q	2023-11-13
Q2 2023	$22.1M	+$3.83M	+21%	Jun 30, 2023	10-Q	2023-08-08
Q1 2023	$25.3M	+$8.19M	+47.9%	Mar 31, 2023	10-Q	2023-05-10
Q4 2022	$21.5M	+$7.86M	+57.7%	Dec 31, 2022	10-K	2024-03-21
Q3 2022	$20.1M	+$5.33M	+36.1%	Sep 30, 2022	10-Q	2022-11-08
Q2 2022	$18.2M	+$5.15M	+39.4%	Jun 30, 2022	10-Q	2022-08-04
Q1 2022	$17.1M	+$5.79M	+51.3%	Mar 31, 2022	10-Q	2022-05-04
Q4 2021	$13.6M	+$770K	+5.99%	Dec 31, 2021	10-K	2023-03-15
Q3 2021	$14.8M	-$169M	-92%	Sep 30, 2021	10-Q	2021-11-09
Q2 2021	$13.1M			Jun 30, 2021	10-Q	2021-08-12
Q1 2021	$11.3M			Mar 31, 2021	10-Q	2021-05-11
Q4 2020	$12.9M	+$10.2M	+377%	Dec 31, 2020	10-K	2022-02-24
Q3 2020	$184M			Sep 30, 2020	10-Q	2020-11-18
Q4 2019	$2.7M			Dec 31, 2019	10-K	2021-03-23

* An asterisk sign (*) next to the value indicates that the value is likely invalid.